Treatment Duration of Adjuvant Immune Checkpoint Inhibitors in Hepatocellular Carcinoma Patients at High Risk of Recurrence after Resection: A Prospective, Multicentric Cohort Study

<p>Introduction: Adjuvant immune checkpoint inhibitors (ICIs) may improve recurrence-free survival (RFS) in patients with hepatocellular carcinoma (HCC). This study evaluated the effects of adjuvant ICI treatment duration on RFS and overall survival (OS) among patients with HCC at high ri...

Бүрэн тодорхойлолт

Номзүйн дэлгэрэнгүй

Үндсэн зохиолчид:	Jia-Yong Su, Shao-Ping Liu, Xiao-Ling Xu, Jun-Jie Ou, Po-Hua Ye, Bin-Tong Zhao, Jia-Song Chen, Qiu-Mei Luo, Jin-Rong Liu, Fei-Min Tang, Jian-Rong Li, Da-Long Yang, Zhu-Jian Deng, Li-Xin Pan, Yao-Jie Li, Le Li, Zhen-Ming Qin, Xiu-Mei Liang, Yi-Li Ma, Liang Ma, Jian-Hong Zhong
Формат:	Artigo
Хэл сонгох:	Inglês
Хэвлэсэн:	Karger Publishers 2025-01-01
Цуврал:	Liver Cancer
Онлайн хандалт:	https://karger.com/article/doi/10.1159/000542954
Шошгууд:	Шошго нэмэх Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!